APA (7th ed.) Citation

Du, X., Dong, Y., Liu, J., Su, Y., Zhu, Y., Pan, J., . . . Xue, W. (2023). Baseline PSMA‐PET/CT as a predictor of PSA persistence following radical prostatectomy in high‐risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy. The Prostate, 83(11), 1112-1120. https://doi.org/10.1002/pros.24553

Chicago Style (17th ed.) Citation

Du, Xinxing, et al. "Baseline PSMA‐PET/CT as a Predictor of PSA Persistence Following Radical Prostatectomy in High‐risk Nonmetastatic Prostate Cancer Patients Receiving Neoadjuvant Therapy." The Prostate 83, no. 11 (2023): 1112-1120. https://doi.org/10.1002/pros.24553.

MLA (9th ed.) Citation

Du, Xinxing, et al. "Baseline PSMA‐PET/CT as a Predictor of PSA Persistence Following Radical Prostatectomy in High‐risk Nonmetastatic Prostate Cancer Patients Receiving Neoadjuvant Therapy." The Prostate, vol. 83, no. 11, 2023, pp. 1112-1120, https://doi.org/10.1002/pros.24553.